BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33632160)

  • 1. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.
    Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML;
    BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
    Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis.
    Nubé MJ; Peters SAE; Blankestijn PJ; Canaud B; Davenport A; Grooteman MPC; Asci G; Locatelli F; Maduell F; Morena M; Ok E; Torres F; Bots ML;
    Nephrol Dial Transplant; 2017 Mar; 32(3):548-555. PubMed ID: 28025382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
    Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
    BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.
    Hazelbag CM; Peters SAE; Blankestijn PJ; Bots ML; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Hoes AW; Groenwold RHH;
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii31-ii39. PubMed ID: 28339826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials.
    Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ
    Am J Kidney Dis; 2014 Jun; 63(6):968-78. PubMed ID: 24685515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
    Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why choose high volume online post-dilution hemodiafiltration?
    Basile C; Davenport A; Blankestijn PJ
    J Nephrol; 2017 Apr; 30(2):181-186. PubMed ID: 27586123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry.
    Mercadal L; Franck JE; Metzger M; Urena Torres P; de Cornelissen F; Edet S; Béchade C; Vigneau C; Drüeke T; Jacquelinet C; Stengel B;
    Am J Kidney Dis; 2016 Aug; 68(2):247-255. PubMed ID: 26724836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration.
    Jansz TT; Özyilmaz A; Grooteman MPC; Hoekstra T; Romijn M; Blankestijn PJ; Bots ML; van Jaarsveld BC
    BMJ Open; 2018 Mar; 8(3):e019900. PubMed ID: 29523566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.
    Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ
    Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Evidence in Haemodiafiltration.
    Locatelli F; Violo L; Longhi S; Del Vecchio L
    Blood Purif; 2015; 40 Suppl 1():24-9. PubMed ID: 26344510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.
    Locatelli F; Karaboyas A; Pisoni RL; Robinson BM; Fort J; Vanholder R; Rayner HC; Kleophas W; Jacobson SH; Combe C; Port FK; Tentori F
    Nephrol Dial Transplant; 2018 Apr; 33(4):683-689. PubMed ID: 29040687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of hemodiafiltration and change in cardiovascular parameters.
    Mostovaya IM; Bots ML; van den Dorpel MA; Grooteman MP; Kamp O; Levesque R; Ter Wee PM; Nubé MJ; Blankestijn PJ
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):520-6. PubMed ID: 24408114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.